Veterinary Medicines

EURICAN DAPPI-L, κόνις και διαλύτης για ενέσιμο εναιώρημα για σκύλους

Authorised
  • Canine distemper virus, strain BA5, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine parvovirus, strain CAG2, Live
  • Canine parainfluenza virus, strain CGF 2004/75, Live
  • Canine parainfluenza virus 2, Inactivated
Download as PDF

Identifikacija zdravila

Ime zdravila:
EURICAN DAPPI-L, κόνις και διαλύτης για ενέσιμο εναιώρημα για σκύλους
Učinkovina:
Ciljne živalske vrste:
Pot uporabe:
  • Subkutana uporaba

Podatki o zdravilu

Učinkovina / Jakost:
  • Na voljo samo v English
    10000.00
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    316.22
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    79.43
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
    50.12
    cell culture infective dose 50
    /
    1.00
    millilitre(s)
  • Na voljo samo v English
Farmacevtska oblika:
  • Prašek in vehikel za suspenzijo za injiciranje
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomsko-terapevtsko-kemična veterinarska oznaka (ATCvet):
  • QI07AI02
Pravni status za dobavo / izdajo zdravila:
  • Zdravilo, ki se izdaja na veterinarski recept
Status dovoljenja:
  • Valid
Authorised in:
  • Greece
Opis ovojnine:

Dodatne informacije

Entitlement type:
Pravna podlaga za izdajo dovoljenja za promet z zdravilom:
Imetnik dovoljenja za promet z zdravilom:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Proizvodna mesta, odgovorna za sproščanje serij:
  • Boehringer Ingelheim Animal Health France
Pristojni organ:
  • National Organization For Medicines
Številka dovoljenja :
  • 38630/27-04-2017/K-0225001
Datum spremembe statusa dovoljenja:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."